Just saw your post, shocking news. If this is true, it means that relationship between management team and Lew has gone even worse. IMO this is not an attempt to raise capital to reduce debt (as its debt is already managed since the previous raise), but to further dilute Lew's holding in Myer, reduce his influence.
- A raise of A$200m @0.3 would result in additional 667m shares, comparing with current share outstanding of ~820m shares, this would dilute current shareholding by ~ 45%. This IMO is a strategic play in managerial terms, but would be a disaster for all existing shareholders. Maybe Lew will make a defensive play, but either way, corporate instability will further impact Myer's business in near term.
Personally, though I hold pessimistic view over Myer's outlook, I still hope this right issue is not true, just hate to see an iconic company getting screwed over by management team like that. It's christmas, give the shareholders a break.
- Forums
- ASX - By Stock
- MYR
- Ann: Q2 Trading Update
MYR
myer holdings limited
Add to My Watchlist
0.83%
!
60.5¢

Ann: Q2 Trading Update, page-235
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
60.5¢ |
Change
0.005(0.83%) |
Mkt cap ! $1.045B |
Open | High | Low | Value | Volume |
60.0¢ | 61.0¢ | 59.5¢ | $4.694M | 7.796M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 99148 | 59.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
61.0¢ | 109457 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 99148 | 0.595 |
25 | 251521 | 0.590 |
12 | 163279 | 0.585 |
24 | 492962 | 0.580 |
4 | 67134 | 0.575 |
Price($) | Vol. | No. |
---|---|---|
0.610 | 49457 | 6 |
0.615 | 34091 | 3 |
0.620 | 124650 | 5 |
0.625 | 9018 | 2 |
0.630 | 18498 | 2 |
Last trade - 16.15pm 26/06/2025 (20 minute delay) ? |
Featured News
MYR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online